Literature DB >> 20933021

Sickness behaviors following medial frontal cortical contusions in male rats.

Kimberly J Grossman1, Cynthia W Goss, Donald G Stein.   

Abstract

Behaviors associated with sickness (food consumption, weight maintenance, exploratory activity and grooming frequency) were examined on post-surgical days 1, 3, 5, 7 and 9 in male rats treated with progesterone (4 mg/kg) and/or vehicle. Rats with medial frontal cortex contusions showed reduced food consumption on days 1 and 3 (p < 0.01), reduced weight maintenance on days 1, 3, 5, 7 and 9 (p < 0.01), reduced grooming frequency on day 1 (p < .01), and reduced exploratory activity on day 1 (p < 0.01), after injury compared to sham rats. Contusion induced behaviors were not attenuated with 5 days of progesterone treatment (p > 0.05). Progesterone did reduce lesion size at 9 days after injury (p < 0.05). Our results suggest sickness behaviors occur after traumatic brain injury and that they might not respond to some neurosteroidal agents.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20933021      PMCID: PMC4865680          DOI: 10.1016/j.bbr.2010.09.029

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  34 in total

1.  Effects of the duration of progesterone treatment on the resolution of cerebral edema induced by cortical contusions in rats.

Authors:  R Galani; S W Hoffman; D G Stein
Journal:  Restor Neurol Neurosci       Date:  2001       Impact factor: 2.406

2.  Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins.

Authors:  R Cavalli; E Peira; O Caputo; M R Gasco
Journal:  Int J Pharm       Date:  1999-05-10       Impact factor: 5.875

3.  The induction of excessive grooming in the rat by intraventricular application of peptides derived from ACTH: structure-activity studies.

Authors:  W H Gispen; V M Wiegant; H M Greven; D de Wied
Journal:  Life Sci       Date:  1975-08-15       Impact factor: 5.037

4.  Progesterone facilitates the acquisition of avoidance learning and protects against subcortical neuronal death following prefrontal cortex ablation in the rat.

Authors:  E T Asbury; M E Fritts; J E Horton; W L Isaac
Journal:  Behav Brain Res       Date:  1998-12       Impact factor: 3.332

Review 5.  Central interleukin-1 receptors as mediators of sickness.

Authors:  K W Kelley; K Hutchison; R French; R M Bluthé; P Parnet; R W Johnson; R Dantzer
Journal:  Ann N Y Acad Sci       Date:  1997-08-14       Impact factor: 5.691

Review 6.  Biological basis of the behavior of sick animals.

Authors:  B L Hart
Journal:  Neurosci Biobehav Rev       Date:  1988       Impact factor: 8.989

7.  Neuroprotective effects of progesterone on damage elicited by acute global cerebral ischemia in neurons of the caudate nucleus.

Authors:  Miguel Cervantes; María Dolores González-Vidal; Rodrigo Ruelas; Alfonso Escobar; Gabriela Moralí
Journal:  Arch Med Res       Date:  2002 Jan-Feb       Impact factor: 2.235

8.  Both estrogen and progesterone attenuate edema formation following diffuse traumatic brain injury in rats.

Authors:  Christine A O'Connor; Ibolja Cernak; Robert Vink
Journal:  Brain Res       Date:  2005-10-26       Impact factor: 3.252

9.  Serum progesterone levels correlate with decreased cerebral edema after traumatic brain injury in male rats.

Authors:  D W Wright; M E Bauer; S W Hoffman; D G Stein
Journal:  J Neurotrauma       Date:  2001-09       Impact factor: 5.269

10.  Effects of progesterone on the inflammatory response to brain injury in the rat.

Authors:  Kimberly J Grossman; Cynthia W Goss; Donald G Stein
Journal:  Brain Res       Date:  2004-05-15       Impact factor: 3.252

View more
  8 in total

1.  Sensorimotor behavioral tests for use in a juvenile rat model of traumatic brain injury: assessment of sex differences.

Authors:  Kristin L Russell; Katrina M Kutchko; Stephen C Fowler; Nancy E J Berman; Beth Levant
Journal:  J Neurosci Methods       Date:  2011-05-11       Impact factor: 2.390

Review 2.  Progesterone for neuroprotection in pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Emin Fidan; Rachel M Stanley; Corina Noje; Hülya Bayir
Journal:  Pediatr Crit Care Med       Date:  2015-03       Impact factor: 3.624

3.  Impact of aging on the immune response to traumatic brain injury (AIm:TBI) study protocol.

Authors:  Hilaire J Thompson; Frederick Rivara; Kyra J Becker; Ronald Maier; Nancy Temkin
Journal:  Inj Prev       Date:  2019-09-03       Impact factor: 2.399

4.  Low brain DHA content worsens sensorimotor outcomes after TBI and decreases TBI-induced Timp1 expression in juvenile rats.

Authors:  Kristin L Russell; Nancy E J Berman; Beth Levant
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-06-21       Impact factor: 4.006

5.  Effects of Progesterone on Preclinical Animal Models of Traumatic Brain Injury: Systematic Review and Meta-analysis.

Authors:  Raif Gregorio Nasre-Nasser; Maria Manoela Rezende Severo; Gabriel Natan Pires; Mariana Appel Hort; Bruno Dutra Arbo
Journal:  Mol Neurobiol       Date:  2022-08-04       Impact factor: 5.682

Review 6.  Sex-related responses after traumatic brain injury: Considerations for preclinical modeling.

Authors:  Claudia B Späni; David J Braun; Linda J Van Eldik
Journal:  Front Neuroendocrinol       Date:  2018-05-18       Impact factor: 8.606

Review 7.  Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

Authors:  Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer
Journal:  J Neurotrauma       Date:  2014-01-15       Impact factor: 5.269

Review 8.  Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?

Authors:  Dominique Lerouet; Catherine Marchand-Leroux; Valérie C Besson
Journal:  Fundam Clin Pharmacol       Date:  2021-03-13       Impact factor: 2.747

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.